Disc Medicine (IRON) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $56.65, +1.63% vs the prior close of $55.74.
- Volume 699.80K shares, 1.3x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
IRON rises 1.6% to $56.65. Closed at $56.65, +1.63% vs the prior close of $55.74. Day range $55.95–$58.08, opened at $56.66.
IRON daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — IRON rises 1.6% to $56.65
- Closed at $56.65, +1.63% vs the prior close of $55.74. Day range $55.95–$58.08, opened at $56.66.
- Volume was 699.80K shares, 1.3x its 50-day average of 522.14K.
- Price is -21.2% vs its 50-day average ($71.92) and -19.9% vs its 200-day average ($70.76).
- 52-week range $40.00–$99.50; today's close sits at 28% of that range, 43.1% below the 52-week high.
Oct 14, 2026 — IRON dips 1.5% to $55.74, a 52-week low, 3 down days in a row
- Closed at $55.74, -1.52% vs the prior close of $56.60. Day range $55.48–$58.83, opened at $56.21.
- Volume was 430.70K shares, 0.8x its 50-day average of 521.13K.
- Price is -23.0% vs its 50-day average ($72.37) and -21.4% vs its 200-day average ($70.87).
- 52-week range $40.00–$99.50; today's close sits at 26% of that range, 44.0% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — IRON slides 6.4% to $56.60, a 6-month low
- Closed at $56.60, -6.42% vs the prior close of $60.48. Day range $56.47–$60.48, opened at $60.16.
- Volume was 599.00K shares, 1.2x its 50-day average of 515.03K.
- Price is -22.3% vs its 50-day average ($72.81) and -20.3% vs its 200-day average ($70.99).
- 52-week range $40.00–$99.50; today's close sits at 28% of that range, 43.1% below the 52-week high.
Oct 12, 2026 — IRON dips 2.5% to $60.48, a 6-month low
- Closed at $60.48, -2.55% vs the prior close of $62.06. Day range $60.35–$62.76, opened at $62.20.
- Volume was 657.20K shares, 1.3x its 50-day average of 509.17K.
- Price is -17.4% vs its 50-day average ($73.21) and -15.0% vs its 200-day average ($71.11).
- 52-week range $40.00–$99.50; today's close sits at 34% of that range, 39.2% below the 52-week high.
Oct 9, 2026 — IRON rises 2.1% to $62.06
- Closed at $62.06, +2.12% vs the prior close of $60.77. Day range $60.03–$63.50, opened at $60.67.
- Volume was 691.10K shares, 1.4x its 50-day average of 502.84K.
- Price is -15.6% vs its 50-day average ($73.54) and -12.9% vs its 200-day average ($71.21).
- 52-week range $40.00–$99.50; today's close sits at 37% of that range, 37.6% below the 52-week high.
Oct 8, 2026 — IRON dips 0.7% to $60.77, a 6-month low, 4 down days in a row
- Closed at $60.77, -0.67% vs the prior close of $61.18. Day range $58.22–$61.58, opened at $60.71.
- Volume was 846.80K shares, 1.7x its 50-day average of 493.08K.
- Price is -17.7% vs its 50-day average ($73.88) and -14.8% vs its 200-day average ($71.30).
- 52-week range $40.00–$99.50; today's close sits at 35% of that range, 38.9% below the 52-week high.
- That makes 4 straight losses.
Oct 7, 2026 — IRON dips 0.8% to $61.18, a 6-month low, 3 down days in a row
- Closed at $61.18, -0.76% vs the prior close of $61.65. Day range $60.02–$62.97, opened at $61.20.
- Volume was 562.80K shares, 1.1x its 50-day average of 490.78K.
- Price is -17.5% vs its 50-day average ($74.14) and -14.3% vs its 200-day average ($71.39).
- 52-week range $40.00–$99.50; today's close sits at 36% of that range, 38.5% below the 52-week high.
- That makes 3 straight losses.
Oct 6, 2026 — IRON dips 2.7% to $61.65, a 6-month low on 3.0x normal volume
- Closed at $61.65, -2.65% vs the prior close of $63.33. Day range $61.31–$64.66, opened at $63.70.
- Volume was 1.42M shares, 3.0x its 50-day average of 469.44K — unusually heavy trading.
- Price is -17.1% vs its 50-day average ($74.41) and -13.8% vs its 200-day average ($71.54).
- 52-week range $40.00–$99.50; today's close sits at 36% of that range, 38.0% below the 52-week high.
Oct 5, 2026 — IRON dips 1.8% to $63.33, a 6-month low
- Closed at $63.33, -1.83% vs the prior close of $64.51. Day range $63.01–$65.57, opened at $65.13.
- Volume was 456.30K shares, 1.0x its 50-day average of 468.38K.
- Price is -15.2% vs its 50-day average ($74.67) and -11.6% vs its 200-day average ($71.67).
- 52-week range $40.00–$99.50; today's close sits at 39% of that range, 36.4% below the 52-week high.
Oct 2, 2026 — IRON rises 1.4% to $64.51
- Closed at $64.51, +1.41% vs the prior close of $63.61. Day range $63.81–$66.55, opened at $64.56.
- Volume was 684.70K shares, 1.5x its 50-day average of 460.17K.
- Price is -13.8% vs its 50-day average ($74.88) and -10.2% vs its 200-day average ($71.81).
- 52-week range $40.00–$99.50; today's close sits at 41% of that range, 35.2% below the 52-week high.
IRON latest news & SEC filings
Every SEC filing by or about IRON in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Quisel John D converted options/RSUs into 36,000 shares at $1.01 (≈$36.36K) on Sep 15, 2026; now holds 262,064
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 15, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Bitterman Kevin sold 27,136 shares at $70.11 (≈$1.90M) on Sep 11, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 11, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Sep 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Bitterman Kevin sold 912 shares at $79.96 (≈$72.92K) on Sep 4, 2026
- Bitterman Kevin sold 18 shares at $79.96 (≈$1.44K) on Sep 4, 2026
- Bitterman Kevin sold 759 shares at $79.96 (≈$60.69K) on Sep 4, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 4, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 4, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 6, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 30, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$59.53M (prior year -$55.25M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$1.54 (prior year -$1.58) (loss narrowed vs Jun 30, 2025)
Jul 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jun 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.03 — Took on a new material debt or financial obligation.
Jun 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Things to know before you trade IRON
- Last results release: Jul 30, 2026 (8-K Item 2.02). Previous ones: May 5, 2026, Feb 26, 2026, Jan 12, 2026. Based on that rhythm, the next report is likely around Oct 29, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.74% (largest 6.4%).
- Liquidity: about 655.88K shares (≈$37.16M) trade per day on average.
- 52-week position: $56.65 vs a range of $40.00–$99.50 (28% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Kevin Bitterman sold 27,136 shares on Sep 11, 2026.
- Latest filings: 8-K Sep 10, 2026; 10-Q Jul 30, 2026; 8-K Jul 30, 2026.
- Share count: 38.39M shares outstanding (Jul 23, 2026), +10.4% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
IRON market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 56.66 | 58.08 | 55.95 | 56.65 | 699.80K |
| Oct 14, 2026 | 56.21 | 58.83 | 55.48 | 55.74 | 430.70K |
| Oct 13, 2026 | 60.16 | 60.48 | 56.47 | 56.60 | 599.00K |
| Oct 12, 2026 | 62.20 | 62.76 | 60.35 | 60.48 | 657.20K |
| Oct 9, 2026 | 60.67 | 63.50 | 60.03 | 62.06 | 691.10K |
| Oct 8, 2026 | 60.71 | 61.58 | 58.22 | 60.77 | 846.80K |
| Oct 7, 2026 | 61.20 | 62.97 | 60.02 | 61.18 | 562.80K |
| Oct 6, 2026 | 63.70 | 64.66 | 61.31 | 61.65 | 1.42M |
| Oct 5, 2026 | 65.13 | 65.57 | 63.01 | 63.33 | 456.30K |
| Oct 2, 2026 | 64.56 | 66.55 | 63.81 | 64.51 | 684.70K |
| Oct 1, 2026 | 65.27 | 65.94 | 63.50 | 63.61 | 771.80K |
| Sep 30, 2026 | 66.08 | 66.08 | 64.24 | 65.46 | 671.50K |
| Sep 29, 2026 | 64.93 | 66.29 | 64.05 | 65.87 | 784.10K |
| Sep 28, 2026 | 64.83 | 66.25 | 63.96 | 64.92 | 480.50K |
| Sep 25, 2026 | 66.89 | 66.89 | 64.59 | 65.24 | 427.20K |
| Sep 24, 2026 | 66.09 | 66.58 | 64.31 | 66.44 | 455.60K |
| Sep 23, 2026 | 68.54 | 68.94 | 65.31 | 66.09 | 541.80K |
| Sep 22, 2026 | 69.65 | 69.79 | 67.68 | 68.48 | 450.80K |
| Sep 21, 2026 | 69.84 | 69.84 | 67.15 | 68.49 | 406.50K |
| Sep 18, 2026 | 69.13 | 69.60 | 67.71 | 69.53 | 1.08M |
About Disc Medicine
Disc Medicine (IRON) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in WATERTOWN, MA. Fiscal year ends December 31. SEC CIK 1816736.
IRON board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Nadim Ahmed | Director | Jun 23, 2026 |
| Kevin Bitterman | Director | Sep 15, 2026 |
| Mark Chin | Director | Jun 23, 2026 |
| Georges Gemayel | Director | Jun 23, 2026 |
| Donald William Nicholson | Director | Jun 23, 2026 |
| John D Quisel | Chief Executive Officer | Sep 16, 2026 |
| Liam Ratcliffe | Director | Jun 23, 2026 |
| William Richard White | Director | Jun 23, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Jean M. Franchi | Chief Financial Officer | Apr 15, 2026 |
| Rahul Khara | Chief Legal Officer | Aug 7, 2026 |
| John D Quisel | Chief Executive Officer | Sep 16, 2026 |
| William Jacob Savage | Chief Medical Officer | Apr 15, 2026 |
| Pamela Stephenson | Chief Commercial Officer | Feb 17, 2026 |
| Jonathan Yen-Wen Yu | Chief Operating Officer | Aug 26, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 11, 2026 | Kevin Bitterman | Sale | 27,136 | $70.11 |
| Sep 4, 2026 | Kevin Bitterman | Sale | 912 | $79.96 |
| Sep 4, 2026 | Kevin Bitterman | Sale | 18 | $79.96 |
| Sep 4, 2026 | Kevin Bitterman | Sale | 759 | $79.96 |
| Sep 3, 2026 | Kevin Bitterman | Sale | 54 | $79.98 |
| Sep 3, 2026 | Kevin Bitterman | Sale | 2,810 | $79.98 |
| Sep 3, 2026 | Kevin Bitterman | Sale | 2,339 | $79.98 |
| Sep 2, 2026 | Kevin Bitterman | Sale | 26,542 | $80.17 |
| Sep 2, 2026 | Kevin Bitterman | Sale | 22,090 | $80.17 |
| Sep 2, 2026 | Kevin Bitterman | Sale | 10 | $80.98 |
| Sep 2, 2026 | Kevin Bitterman | Sale | 9 | $80.98 |
| Sep 2, 2026 | Kevin Bitterman | Sale | 2 | $80.98 |
| Sep 2, 2026 | Kevin Bitterman | Sale | 511 | $80.17 |
| Sep 1, 2026 | Kevin Bitterman | Sale | 70 | $79.95 |
| Sep 1, 2026 | Kevin Bitterman | Sale | 58 | $79.95 |
IRON financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-212.18M | -6.01 | $-180.39M |
| Dec 31, 2024 | — | $-109.36M | -3.96 | $-93.93M |
| Dec 31, 2023 | — | $-76.43M | -3.42 | $-73.46M |
| Dec 31, 2022 | — | $-46.83M | -45.05 | $-42.25M |
| Dec 31, 2021 | — | $-35.97M | -40.95 | $-27.53M |
Latest balance sheet: total assets $735.07M, total liabilities $90.91M, cash $98.68M (as of Jun 30, 2026).
IRON earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 30, 2026 | 8-K Item 2.02 (results) | $79.21 |
| May 5, 2026 | 8-K Item 2.02 (results) | $67.59 |
| Feb 26, 2026 | 8-K Item 2.02 (results) | $67.91 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $79.02 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $87.00 |
| Oct 20, 2025 | 8-K Item 2.02 (results) | $87.17 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $57.07 |
| May 7, 2025 | 8-K Item 2.02 (results) | $43.55 |
| Feb 27, 2025 | 8-K Item 2.02 (results) | $54.50 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $63.26 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on IRON
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.